Lifestyle Counseling for Medication Adherence in Glaucoma

References

• Newman-Casey P, Anne D, Megan RAL. Systematic review of educational interventions to improve glaucoma medication adherence: an update in 2015. Expert Rev Ophthalmol. 2016;11(1):5–20. doi:10.1586/17469899.2016.1134318
   PubMed Web of Science ®Google Scholar
• Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398–2402. doi:10.1016/j.ophtha.2011.05.013
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020;127(4):477–483. doi:10.1016/j.ophtha.2019.10.022
   PubMed Web of Science ®Google Scholar
• Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl1):S57–68. doi:10.1016/j.survophthal.2008.08.002
   PubMed Web of Science ®Google Scholar
• Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011;5:441–463. doi:10.2147/PPA.S23780
   PubMed Web of Science ®Google Scholar
• Olthoff CMG, Schouten JSAG, van de Borne BW, Webers CAB. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–961. doi:10.1016/j.ophtha.2004.12.035
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology. 2015;122(10):2010–2021. doi:10.1016/j.ophtha.2015.06.039
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026
   PubMed Web of Science ®Google Scholar
• Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393–398. doi:10.1097/00061198-200310000-00001
   PubMed Web of Science ®Google Scholar
• Sanchez FG, Mansberger SL, Newman-Casey PA. Predicting Adherence with the Glaucoma Treatment Compliance Assessment Tool. J Glaucoma. 2020;29(11):1017–1024. doi:10.1097/IJG.0000000000001616
   Web of Science ®Google Scholar
• Peralta E, Muir KW, Rosdahl JA. Systematic review of knowledge assessments for glaucoma patients. Semin Ophthalmol. 2018;33(3):377–388. doi:10.1080/08820538.2016.1247180
   PubMed Web of Science ®Google Scholar
• Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286–2293. doi:10.1016/j.ophtha.2009.05.026
   PubMed Web of Science ®Google Scholar
• Sleath B, Blalock SJ, Carpenter DM, et al. Provider education about glaucoma and glaucoma medications during videotaped medical visits. J Ophthalmol. 2014;2014:1–7. doi:10.1155/2014/238939
   Web of Science ®Google Scholar
• Carpenter DM, Blalock SJ, Sayner R, et al. Communication predicts medication self-efficacy in glaucoma patients. Optom Vis Sci. 2016;93(7):731–737. doi:10.1097/OPX.0000000000000856
   Web of Science ®Google Scholar
• Gray TA, Fenerty C, Harper R, et al. Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye. 2012;26(3):407–417. doi:10.1038/eye.2011.269
   PubMed Web of Science ®Google Scholar
• Carpenter DM, Tudor GE, Sayner R, et al. Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients. Patient Educ Couns. 2015;98(12):1558–1567. doi:10.1016/j.pec.2015.07.001
   Web of Science ®Google Scholar
• Newman-Casey PA, Musser JA, Niziol LM, et al. Integrating patient education into the glaucoma clinical encounter: a lean analysis. J Glaucoma. 2019;28(5):415–422. doi:10.1097/IJG.0000000000001192
   Web of Science ®Google Scholar
• Sleath B, Blalock SJ, Carpenter DM, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2015;122(4):748–754. doi:10.1016/j.ophtha.2014.11.001
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Broadway DC. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol. 2014;14:32. doi:10.1186/1471-2415-14-32
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Niziol LM, Mackenzie CK, et al. Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design. Pilot Feasibility Stud. 2018;4(1):1–13. doi:10.1186/s40814-018-0320-6
   Google Scholar
• Morrison F, Shubina M, Turchin A. Lifestyle counseling in routine care and long-term glucose, blood pressure, and cholesterol control in patients with diabetes. Diabetes Care. 2012;35(2):334–341. doi:10.2337/dc11-1635
   PubMed Web of Science ®Google Scholar
• Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142(6):403–411. doi:10.7326/0003-4819-142-6-200503150-00006
   PubMed Web of Science ®Google Scholar
• Hughes TA, Gwynne JT, Switzer BR, Herbst C, White G. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med. 1984;77(1):7–17. doi:10.1016/0002-9343(84)90429-7
   Web of Science ®Google Scholar
• The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, Phase II. Arch Intern Med. 1997;157(6):657–667.
   Google Scholar
• Blumenthal JA, Babyak MA, Hinderliter A, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med. 2010;170(2):126–135. doi:10.1001/archinternmed.2009.470
   PubMed Web of Science ®Google Scholar
• Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289(16):2083–2093. doi:10.1001/jama.289.16.2083
   PubMed Web of Science ®Google Scholar
• Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3–10. doi:10.1056/NEJM200101043440101
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Kang JH. Lifestyle, nutrition, and glaucoma. J Glaucoma. 2009;18(6):423–428. doi:10.1097/IJG.0b013e31818d3899
   PubMed Web of Science ®Google Scholar
• Hodapp E, Parrish RK, Anderson Douglas R. Clinical Decisions in Glaucoma. St. Louis, Mo.: Mosby; 1993.
   Google Scholar
• Cohen S, Janicki-Deverts D. Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J Appl Soc Psychol. 2012;42(6):1320–1334. doi:10.1111/j.1559-1816.2012.00900.x
   Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Microsoft Office Excel 2007. Microsoft, Redmond, WA. 
   Google Scholar
• R Core Team (2014). R: A language and environment for statistical computing. R Foundation for StatisticalComputing, Vienna, Austria. Available from: http://www.R-project.org/.
   Google Scholar
• Chang DS, Friedman DS, Frazier T, Plyler R, Boland MV. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology. 2013;120(7):1396–1402. doi:10.1016/j.ophtha.2013.01.002
   Web of Science ®Google Scholar
• Friedman DS, Hahn SR, Gelb L, et al. Doctor–patient communication, health-related beliefs, and adherence in glaucoma: results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1320–1327.e3. doi:10.1016/j.ophtha.2007.11.023
   PubMed Web of Science ®Google Scholar
• Boland MV, Chang DS, Frazier T, Plyler R, Friedman DS. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the Automated Dosing Reminder Study. JAMA Ophthalmol. 2014;132(7):838–844. doi:10.1001/jamaophthalmol.2014.856
   PubMed Web of Science ®Google Scholar
• Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. J Glaucoma. 2007;16(6):513–520. doi:10.1097/IJG.0b013e31804a5ec6
   Web of Science ®Google Scholar
• Kang JH, Wu J, Cho E, et al. Contribution of the nurses’ health study to the epidemiology of cataract, age-related macular degeneration, and glaucoma. Am J Public Health. 2016;106(9):1684–1689. doi:10.2105/AJPH.2016.303317
   PubMed Web of Science ®Google Scholar
• Perez CI, Singh K, Lin S. Relationship of lifestyle, exercise, and nutrition with glaucoma. Curr Opin Ophthalmol. 2019;30(2):82–88. doi:10.1097/ICU.0000000000000553
   PubMed Web of Science ®Google Scholar
• Hecht I, Achiron A, Man V, Burgansky-Eliash Z. Modifiable factors in the management of glaucoma: a systematic review of current evidence. Graefes Arch Clin Exp Ophthalmol. 2017;255(4):789–796. doi:10.1007/s00417-016-3518-4
   PubMed Web of Science ®Google Scholar
• Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515–523. doi:10.1016/0002-9394(86)90939-6
   PubMed Web of Science ®Google Scholar
• Lim MC, Watnik MR, Imson KR, Porter SM, Granier AM. Adherence to glaucoma medication. J Glaucoma. 2013;22(6):439–446. doi:10.1097/ijg.0b013e31824cd0ae
   PubMed Web of Science ®Google Scholar